Tarsus Pharmaceuticals, Inc. · NASDAQ:TARS
Deep Track Capital, LP reported a 5.60% stake in Tarsus Pharmaceuticals, Inc. (Schedule 13G)
Event Jul 21, 2025 · Filed Jul 28, 2025
Deep Track Capital, LP reported a 5.60% stake in Tarsus Pharmaceuticals, Inc., 2,352,960 shares, as a passive investor on Jul 21, 2025. Filed Jul 28, 2025 (Schedule 13G).
- Stake
- 5.60%
- Shares
- 2,352,960
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 5.60% | 2,352,960 |
| Deep Track Biotechnology Master Fund, Ltd. | 5.60% | 2,352,960 |
| David Kroin | 5.60% | 2,352,960 |
Source
Related
- Tarsus Pharmaceuticals, Inc.
- Deep Track Capital, LP
- Tarsus Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Schedule 13G/A · Deep Track Capital, LP · Nov 14, 2025
- Form 4 · Pyott David E I · Sep 17, 2026
- Form 4 · Yarno Wendy L · Sep 17, 2026
- Form 4 · Link William J Phd · Sep 17, 2026
- Form 4 · Azamian Bobak R. · Sep 9, 2026
- Form 4 · Lin Elizabeth Yeu · Sep 9, 2026